| Roche Pharma (Schweiz) AG - Hemlibra 150mg/1ml, Injektionslösung |
| 66694 | | 04 | | Hemlibra 150mg/1ml | | Injektionslösung | | B02BX06 | | Emicizumab | | 06.11.2018 | | |
|
| Composition |
| emicizumabum 150 mg, histidinum, acidum asparticum, argininum, poloxamerum 188, aqua ad iniectabile ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Emicizumabum | 150 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Emicizumabum | 150 mg |
| | | | Inactive agents | Dose |
|---|
| Aspartic Acid | | | Arginine | | | Histidine | | | Poloxamer | 188 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | | 9268.70 | 9550.75 | A | SL | Yes |
|
